0000711404-20-000016.txt : 20200604 0000711404-20-000016.hdr.sgml : 20200604 20200604161918 ACCESSION NUMBER: 0000711404-20-000016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200604 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES, INC. CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 20943180 BUSINESS ADDRESS: STREET 1: 6101 BOLLINGER CANYON ROAD STREET 2: SUITE 500 CITY: SAN RAMON STATE: CA ZIP: 94583 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6101 BOLLINGER CANYON ROAD STREET 2: SUITE 500 CITY: SAN RAMON STATE: CA ZIP: 94583 FORMER COMPANY: FORMER CONFORMED NAME: COOPER COMPANIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 8-K 1 cooper8kq22020form.htm 8-K Document
false0000711404 0000711404 2020-06-04 2020-06-04


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
_______________________________________________
FORM 8-K
 _______________________________________________
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 4, 2020
_______________________________________________
THE COOPER COMPANIES, INC.
(Exact name of registrant as specified in its charter)
 
_______________________________________________
 
 
 
 
 
 
Delaware
 
1-8597
 
94-2657368
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
6101 Bollinger Canyon Road, Suite 500, San Ramon, California 94583
(Address of principal executive offices, including Zip Code)
(925) 460-3600
(Registrant’s telephone number, including area code)
 
_______________________________________________

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Common Stock, $.10 par value
 
COO
 
The New York Stock Exchange






Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 13(a) of the Exchange Act. ☐







ITEM 2.02.    Results of Operations and Financial Condition.

On June 4, 2020, The Cooper Companies, Inc. issued a press release reporting results for its fiscal second quarter ended April 30, 2020. A copy of this release is attached and incorporated by reference.

The contents of any website or hyperlinks mentioned in the release are for informational purposes only and the contents thereof are not part of the release nor incorporated herein by reference.



ITEM 9.01.    Financial Statements and Exhibits.
(d)    Exhibits.

Exhibit
Description
99.1
104.1
Cover Page Interactive Data File (embedded within the Inline XBRL document).









SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.





THE COOPER COMPANIES, INC.



By:     /s/ Albert G. White III    
Albert G. White III
President & Chief Executive Officer
        
Dated: June 4, 2020








EX-99.1 2 cooperq22020pressrelea.htm EXHIBIT 99.1 Exhibit
cooperlogoa24.jpg
 
 
PRESS RELEASE
 
 

CooperCompanies Announces Second Quarter 2020 Results

San Ramon, Calif., June 4, 2020 — CooperCompanies (NYSE: COO) today announced financial results for the fiscal second quarter ended April 30, 2020.
•
Revenue decreased 20% year-over-year to $524.9 million. CooperVision (CVI) revenue down 17% to $402.2 million, and CooperSurgical (CSI) revenue down 28% to $122.7 million.
•
GAAP diluted earnings per share $0.23, down $2.22 or 91% from last year's second quarter.
•
Non-GAAP diluted earnings per share $1.51, down $1.43 or 48% from last year's second quarter. See "Reconciliation of GAAP Results to Non-GAAP Results" below.
 
Commenting on the results, Albert White, Cooper’s president and chief executive officer said, "The COVID-19 pandemic created unprecedented challenges and I’m extremely proud of our more than 12,000 employees and their level of commitment and dedication to our business, their communities and their families during this time.  They’ve enabled us to keep our businesses running strong so we can continue supporting our customers and partners around the world.  Because of them, we are well positioned to come out of this a stronger and more dynamic company."

Second Quarter Operating Results
•
Revenue $524.9 million, down 20% from last year’s second quarter, down 18% in constant currency.
•
Gross margin 62% compared with 66% in last year’s second quarter. On a non-GAAP basis, gross margin was 66%, down from 67% last year driven by sales and product mix.
•
Operating margin 5% compared with 22% in last year’s second quarter. On a non-GAAP basis, operating margin was 17%, down from 27% last year driven by the decline in gross margins combined with heightened operating expenses as a percent of sales.


1




•
Interest expense $12.8 million compared with $18.5 million in last year's second quarter. On a non-GAAP basis, interest expense was $8.8 million compared with $18.5 million last year driven by lower interest rates.
•
Total debt outstanding at the end of the quarter was $1,899.3 million with quarter-end cash and cash equivalents of $79.8 million. Adjusted leverage ratio (net debt over adjusted EBITDA) of 2.18x.
•
Cash provided by operations $25.8 million offset by capital expenditures $89.3 million resulted in negative free cash flow of $63.5 million.

Second Quarter CooperVision (CVI) Operating Results
•
Revenue $402.2 million, down 17% from last year’s second quarter, down 15% in constant currency.
•
Revenue by category:
 
 
 
 
 
 
 
 
Constant Currency
 
 
(In millions)
 
% of CVI Revenue
 
%chg
 
%chg
 
 
2Q20
 
2Q20
 
y/y
 
y/y
 
Toric
$
133.6

 
33%
 
(14)%
 
(13)%
 
Multifocal
45.1

 
11%
 
(9)%
 
(7)%
 
Single-use sphere
116.1

 
29%
 
(14)%
 
(13)%
 
Non single-use sphere, other
107.4

 
27%
 
(25)%
 
(24)%
 
Total
$
402.2

 
100%
 
(17)%
 
(15)%
•Revenue by geography:
 
 
 
 
 
 
 
 
Constant Currency
 
 
(In millions)
 
% of CVI Revenue
 
%chg
 
%chg
 
 
2Q20
 
2Q20
 
y/y
 
y/y
 
Americas
$
149.6

 
38%
 
(23)%
 
(22)%
 
EMEA
154.1

 
38%
 
(15)%
 
(11)%
 
Asia Pacific
98.5

 
24%
 
(10)%
 
(10)%
 
Total
$
402.2

 
100%
 
(17)%
 
(15)%
•
Gross margin 62% compared with 66% in last year’s second quarter. On a non-GAAP basis, gross margin was 66%, compared with 66% last year.

Second Quarter CooperSurgical (CSI) Operating Results
•
Revenue $122.7 million, down 28% from last year's second quarter, down 27% in constant currency.

2




•
Revenue by category:
 
 
 
 
 
 
 
 
Constant Currency
 
 
(In millions)
 
% of CSI Revenue
 
%chg
 
%chg
 
 
2Q20
 
2Q20
 
y/y
 
y/y
 
Office and surgical products
$
69.6

 
57%
 
(34)%
 
(34)%
 
Fertility
53.1

 
43%
 
(17)%
 
(15)%
 
Total
$
122.7

 
100%
 
(28)%
 
(27)%
•
Gross margin 61% compared with 67% in last year’s second quarter. On a non-GAAP basis, gross margin was 65%, down from 70% last year driven by sales and product mix.

Other
•
In fiscal Q2 2020, the company repurchased $47.8 million of common stock, roughly 160.8 thousand shares, under the existing share repurchase program at an average share price of $296.88. The program has $359.7 million of remaining availability and no expiration date.

Fiscal Year 2020 Guidance
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is no longer providing fiscal year 2020 guidance.

Reconciliation of GAAP Results to Non-GAAP Results
To supplement our financial results presented on a GAAP basis, we use non-GAAP measures that we believe are helpful in understanding our results. The non-GAAP measures exclude costs which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Our non-GAAP financial results are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Management uses supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are among the factors management uses in planning and forecasting for future periods. We believe it is useful for investors to understand the effects of these items on our consolidated operating results. Our non-GAAP financial measures may include the following adjustments, and as appropriate, the related income tax effects and changes in income attributable to noncontrolling interests:
•
We exclude the effect of amortization and impairment of intangible assets from our non-GAAP financial results. Amortization of intangible assets will recur in future periods; however, the

3




amounts are affected by the timing and size of our acquisitions. Impairment of intangible assets is a non-recurring cost.
•
We exclude the effect of acquisition and integration expenses and the effect of restructuring expenses from our non-GAAP financial results. Such expenses generally diminish over time with respect to past acquisitions; however, we generally will incur similar expenses in connection with any future acquisitions. We incurred significant expenses in connection with our acquisitions and also incurred certain other operating expenses or income, which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Acquisition and integration expenses include direct effects of acquisition accounting, such as inventory fair value step-up and items such as personnel costs for transitional employees, other acquired employee related costs and integration related professional services. Restructuring expenses include items such as employee severance, product rationalization, facility and other exit costs.
•
We exclude other exceptional or unusual charges or expenses and gains or income.  These can be variable and difficult to predict, such as certain litigation expenses and product transition costs, and are not what we consider as typical of our continuing operations. Investors should consider non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP.
•
We report revenue growth using the non-GAAP financial measure of constant currency so that revenue results may be evaluated excluding the effect of foreign currency rate fluctuations. To present this information, current period revenue for entities reporting in currencies other than the United States dollar are converted into United States dollars at the average foreign exchange rates for the corresponding period in the prior year.
•
We define the non-GAAP measure of free cash flow as cash provided by operating activities less capital expenditures. We believe free cash flow is useful for investors as an additional measure of liquidity because it represents cash that is available to grow the business, make strategic acquisitions, repay debt, buyback common stock or to fund the dividend. Management uses free cash flow internally to understand, manage, make operating decisions and evaluate our business. In addition, we use free cash flow to help plan and forecast future periods.
•
We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations.


4




THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Reconciliation of Selected GAAP Results to Non-GAAP Results
(In millions, except per share amounts)
(Unaudited)

 
Three Months Ended April 30,

 
2020
 
 
 
2020
 
2019
 
 
 
2019

 
GAAP
 
Adjustment
 
Non-GAAP
 
GAAP
 
Adjustment
 
Non-GAAP
Cost of sales
 
$
201.4

 
$
(22.1
)
A
$
179.3

 
$
221.7

 
$
(7.6
)
A
$
214.1

Operating expense excluding amortization and gain on sale of an intangible
 
$
261.0

 
$
(6.7
)
B
$
254.3

 
$
267.8

 
$
(5.1
)
B
$
262.7

Amortization of intangibles
 
$
33.9

 
$
(33.9
)
C
$
—

 
$
36.9

 
$
(36.9
)
C
$
—

Gain on sale of an intangible
 
$
—

 
$
—


$
—

 
$
(19.0
)
 
$
19.0

D
$
—

Interest expense
 
$
12.8

 
$
(4.0
)
E
$
8.8

 
$
18.5

 
$
—


$
18.5

Other expense, net
 
$
6.8

 
$
(4.3
)
F
$
2.5

 
$
0.3

 
$
—


$
0.3

(Benefit) provision for income taxes
 
$
(2.5
)
 
$
7.5

G
$
5.0

 
$
5.7

 
$
6.3

G
$
12.0

Diluted earnings per share
 
$
0.23

 
$
1.28

 
$
1.51

 
$
2.45

 
$
0.49

 
$
2.94

Weighted average diluted shares used
 
49.6

 
 
 
49.6

 
50.0

 
 
 
50.0

A
Fiscal 2020 GAAP cost of sales includes $22.1 million primarily related to COVID-19 and other manufacturing related costs, resulting in fiscal 2020 GAAP gross margin of 62% as compared to fiscal 2020 non-GAAP gross margin of 66%. Fiscal 2019 GAAP cost of sales includes $7.6 million of costs primarily related to acquisitions, integration and other manufacturing related costs, resulting in fiscal 2019 GAAP gross margin of 66% as compared to fiscal 2019 non-GAAP gross margins of 67%.
B
Fiscal 2020 GAAP operating expense comprised of $6.7 million primarily related to CooperSurgical's integration activities and European Medical Devices Regulation (MDR) implementation costs. Fiscal 2019 GAAP operating expense comprised of $5.1 million primarily related to integration activities in CooperSurgical and CooperVision.
C
Amortization expense was $33.9 million and $36.9 million for the fiscal 2020 and 2019 periods, respectively.
D
Fiscal 2019 gain on sale of an intangible asset relates to a gain recognized in CooperSurgical on the sale of an exclusive distribution right of Filshie Clip System. Items A, B, C and D resulted in fiscal 2020 GAAP operating margin of 5% as compared to fiscal 2020 non-GAAP operating margin of 17%, and fiscal 2019 GAAP operating margin of 22% as compared to fiscal 2019 non-GAAP operating margin of 27%.
E
Fiscal 2020 interest expense includes $4.0 million pertaining to the write-off of debt issuance costs related to the repayment and refinancing of the 2016 revolving credit facility and 2017 Term Loan.
F
Fiscal 2020 other expense, net includes $4.3 million of expenses on certain minority investments.
G
Fiscal 2020 and 2019 amounts represent the net change in the (benefit) provision for income taxes that arise from the impact of the above adjustments.

5




THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Reconciliation of Selected GAAP Results to Non-GAAP Results
(In millions, except per share amounts)
(Unaudited)
 
 
Six Months Ended April 30,
 
 
2020
 
 
 
2020
 
2019
 
 
 
2019
 
 
GAAP
 
Adjustment
 
Non-GAAP
 
GAAP
 
Adjustment
 
Non-GAAP
Cost of sales
 
$
421.1

 
$
(30.6
)
A
$
390.5

 
$
431.3

 
$
(13.0
)
A
$
418.3

Operating expense excluding amortization and gain on sale of an intangible
 
$
541.5

 
$
(14.3
)
B
$
527.2

 
$
538.8

 
$
(17.0
)
B
$
521.8

Amortization of intangibles
 
$
68.8

 
$
(68.8
)
C
$
—

 
$
73.5

 
$
(73.5
)
C
$
—

Gain on sale of an intangible
 
$
—

 
$
—

 
$
—

 
$
(19.0
)
 
$
19.0

D
$
—

Interest expense
 
$
24.4

 
$
(4.0
)
E
$
20.4

 
$
36.6

 
$
—

 
$
36.6

Other expense (income), net
 
$
8.9

 
$
(4.3
)
F
$
4.6

 
$
(0.7
)
 
$
—

 
$
(0.7
)
Provision (benefit) for income taxes
 
$
4.4

 
$
15.1

G
$
19.5

 
$
(3.6
)
 
$
19.4

G
$
15.8

Diluted earnings per share
 
$
2.05

 
$
2.15

 
$
4.20

 
$
4.52

 
$
1.30

 
$
5.82

Weighted average diluted shares used
 
49.7

 
 
 
49.7

 
49.9

 
 
 
49.9

A
Fiscal 2020 GAAP cost of sales includes $30.6 million primarily related to COVID-19 and other manufacturing related costs, resulting in fiscal 2020 GAAP gross margin of 64% as compared to fiscal 2020 non-GAAP gross margin of 67%. Fiscal 2019 GAAP cost of sales includes $13.0 million of costs primarily related to acquisitions, integration and other manufacturing related costs, resulting in fiscal 2019 GAAP gross margin of 66%, as compared to fiscal 2019 non-GAAP gross margin of 67%.
B
Fiscal 2020 GAAP operating expense comprised of $14.3 million primarily related to CooperSurgical's integration activities and European Medical Devices Regulation (MDR) implementation costs. Fiscal 2019 GAAP operating expense comprised of $17.0 million in charges primarily related to acquisition and integration activities in CooperSurgical and CooperVision.
C
Amortization expense was $68.8 million and $73.5 million for the fiscal 2020 and 2019 periods, respectively.
D
Fiscal 2019 gain on sale of an intangible asset relates to a gain recognized in CooperSurgical on the sale of an exclusive distribution right of Filshie Clip System. Items A, B, C and D resulted in fiscal 2020 GAAP operating margin of 12% as compared to fiscal 2020 non-GAAP operating margin of 22%, and fiscal 2019 GAAP operating margin of 20% as compared to fiscal 2019 non-GAAP operating margin of 27%.
E
Fiscal 2020 interest expense includes $4.0 million pertaining to the write-off of debt issuance costs related to the repayment and refinancing of the 2016 revolving credit facility and 2017 Term Loan.
F
Fiscal 2020 other expense, net includes $4.3 million of expenses on certain minority investments.
G
Fiscal 2020 and 2019 amounts represent the net change in the provision (benefit) for income taxes that arise from the impact of the above adjustments.


6




Conference Call and Webcast
The Company will host a conference call today at 5:00 PM ET to discuss its fiscal second quarter 2020 results and current corporate developments. The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the "Investor Relations" section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months. A recording of the call will be available beginning at 8:00 PM ET on June 4, 2020 through June 11, 2020. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 7638545.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Forward-Looking Statements
This earnings release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements of which are other than statements of historical fact, including all statements regarding the expected impact of the ongoing COVID-19 pandemic on our business; and statements regarding acquisitions including the acquired companies’ financial position, market position, product development and business strategy, expected cost synergies, expected timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities’ future expenses, sales and diluted earnings per share are forward-looking. In addition, all statements regarding anticipated growth in our revenue, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are forward-looking.  To identify these statements look for words like "believes," "outlook," "probable," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases.  Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. 

7




Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: the effects of the ongoing COVID-19 pandemic and related economic disruptions and new governmental regulations on our business, results of operations, cash flow and financial condition, including but not limited to the potential impact on our sales, operations and supply chain; adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items, including but not limited to, the ongoing COVID-19 pandemic, and escalating global trade barriers including additional tariffs, by countries such as China; adverse changes in global political and economic conditions, and related uncertainty caused by the United Kingdom's withdrawal from the European Union and its potential impact on, among other things, the movement of goods and materials in our supply chain, additional regulatory approvals and requirements, and increased tariffs and duties; changes in tax laws or their interpretation and changes in statutory tax rates, including but not limited to, the U.S., the United Kingdom and other countries may affect our taxation of earnings recognized in foreign jurisdictions and/or negatively impact our effective tax rate; foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our revenues and earnings; our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds; acquisition-related adverse effects including the failure to successfully obtain the anticipated revenues, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms); compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of third-party information, such as HIPAA and the California Consumer Privacy Act in the U.S. and the General Data Protection Regulation requirements in Europe, including but not limited to those resulting from data security breaches; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to the ongoing COVID-19 pandemic, integration of acquisitions, man-made or natural disasters, cybersecurity incidents or other causes; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to technological problems, including any related to our

8




information systems maintenance, enhancements or new system deployments, integrations or upgrades; market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers; disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR), the EU in vitro Diagnostic Medical Devices Regulation (IVDR), and the medical device excise tax under the U.S. Affordable Care Act; legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions; reduced sales, loss of customers and costs and expenses related to product recalls and warning letters; failure to receive, or delays in receiving, regulatory approvals for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payors for our products and services; the requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment; the success of our research and development activities and other start-up projects; dilution to earnings per share from acquisitions or issuing stock; impact and costs incurred from changes in accounting standards and policies; environmental risks, including increasing environmental legislation and the broader impacts of climate change; and other events described in our Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2019, as such Risk Factors may be updated in quarterly filings.
We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.


Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com


9




THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Condensed Balance Sheets
(In millions)
(Unaudited)

 
April 30, 2020
 
October 31, 2019
ASSETS 
ASSETS 
 
 
 
Current assets:


 


Cash and cash equivalents
79.8

 
89.0

Trade receivables, net
368.8

 
435.3

Inventories
568.2

 
506.9

Other current assets
149.4

 
132.2

Total current assets
1,166.2

 
1,163.4

Property, plant and equipment, net
1,196.1

 
1,132.1

Operating lease right-of-use assets
255.5

 
0.0

Goodwill
2,400.0

 
2,428.9

Other intangibles, net
1,337.7

 
1,405.3

Deferred tax assets
77.0

 
78.0

Other assets
77.5

 
66.8

Total assets
$
6,510.0

 
$
6,274.5

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Short-term debt
$
554.5

 
$
563.7

Other current liabilities
470.8

 
546.9

Total current liabilities
1,025.3

 
1,110.6

Long-term debt
1,344.8

 
1,262.6

Deferred tax liabilities
26.8

 
28.0

Long-term tax payable
158.9

 
124.8

Operating lease liabilities
232.7

 
0.0

Accrued pension liability and other
94.0

 
119.9

Total liabilities
2,882.5

 
2,645.9

Stockholders’ equity
3,627.5

 
3,628.6

Total liabilities and stockholders' equity
$
6,510.0

 
$
6,274.5

    



10




THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(In millions, except per share amounts)
(Unaudited)
 
 
Three Months Ended April 30,
 
Six Months Ended
April 30,
 
2020
 
2019
 
2020
 
2019
Net sales
$
524.9

 
$
654.3

 
$
1,171.1

 
$
1,282.4

Cost of sales
201.4

 
221.7

 
421.1

 
431.3

Gross profit
323.5

 
432.6

 
750.0

 
851.1

Selling, general and administrative expense
237.2

 
246.8

 
495.5

 
496.8

Research and development expense
23.8

 
21.0

 
46.0

 
42.0

Amortization of intangibles
33.9

 
36.9

 
68.8

 
73.5

Gain on sale of an intangible
—

 
(19.0
)
 
—

 
(19.0
)
Operating income
28.6

 
146.9

 
139.7

 
257.8

Interest expense
12.8

 
18.5

 
24.4

 
36.6

Other expense, net
6.8

 
0.3

 
8.9

 
(0.7
)
Income before income taxes
9.0

 
128.1

 
106.4

 
221.9

(Benefit) provision for income taxes
(2.5
)
 
5.7

 
4.4

 
(3.6
)
Net income attributable to Cooper stockholders
$
11.5

 
$
122.4

 
$
102.0

 
$
225.5

 
 
 
 
 
 
 
 
Earnings per share - diluted
$
0.23

 
$
2.45

 
$
2.05

 
$
4.52

 
 
 
 
 
 
 
 
Number of shares used to compute diluted earnings per share
49.6

 
50.0

 
49.7

 
49.9











11



EX-101.SCH 3 coo-20200604.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 coo-20200604_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 coo-20200604_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 coo-20200604_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 7 coo-20200604_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 cooperlogoa24.jpg begin 644 cooperlogoa24.jpg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end ZIP 9 0000711404-20-000016-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000711404-20-000016-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
Jun. 04, 2020
Cover page.  
Document Type 8-K
Document Period End Date Jun. 04, 2020
Entity Registrant Name THE COOPER COMPANIES, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 1-8597
Entity Tax Identification Number 94-2657368
Entity Address, Address Line One 6101 Bollinger Canyon Road
Entity Address, Address Line Two Suite 500
Entity Address, City or Town San Ramon
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94583
City Area Code 925
Local Phone Number 460-3600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.10 par value
Trading Symbol COO
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000711404
Amendment Flag false
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &B"Q% ?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ :(+$4"?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !H@L10F(!)&.X K @ $0 &1O8U!R;W!S+V-O M&ULS9+/:L,P#(=?9?B>R$E'8";-I66G#08K;.QF;+4UC?]@:R1]^SE9 MFS*V!]C1TL^?/H%:%83R$5^B#QC)8+H;;>^24&'-CD1! "1U1"M3F1,N-_<^ M6DGY&0\0I#K) T+->0,626I)$B9@$18BZUJMA(HHR<<+7JL%'SYC/\.T NS1 MHJ,$55D!ZZ:)X3SV+=P $XPPVO1=0+T0Y^J?V+D#[)(']^>IW7+8Q+))W"_"L90>> :W:=_+;:;'>/K*MYS0O>%/Q^5S6B>A"621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( &B"Q%",PE"?JP( /X+ 8 >&PO=V]R:W-H965T&UL=5;MCILP$'P5Q ,0=_TGV&9FQV:8L.5#R#=5DT2=:MXQ]20&WIL[ M%R$[ILU47A,U2,[.CM2U"4W35=*QIH^KTJT=9%6*FVZ;GA]DI&Y=Q^2_/6_% M8Q>3^&/AM;G6VBXD53FP*__)]:_A(,TLF:NQ-&97]BMU:_B\95/!RKB:#K]=W[GK8';G1B- MDVB5^XU.-Z5%-U4Q6^G8^WAM>G=]C'?R?*+A!#H1Z$R@6W>64$1R?/@#LQZ39VJ>S+>@4IV> $20%%=8HPIKR">>! ()^+Q!)3:0[QN-0 ).;U&)+>3[5B.0@-.4P@J^W1@F8#@)A); "K[G"(8&3"=X<@F%%7S;,4S =X('G,#\4M]Y#!.P MGN I)S#$U#,<03$"%XMFG,-=9[JE@F"*@@F>?PEQG*U\% MP:P#*H&O-LQUMO%5$,PVH()GGR+?;K_]0#!!7_#L4YCKW'^3,4S@?XSBV:

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ilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.coopercos.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports cooper8kq22020form.htm coo-20200604.xsd coo-20200604_cal.xml coo-20200604_def.xml coo-20200604_lab.xml coo-20200604_pre.xml cooperq22020pressrelea.htm http://xbrl.sec.gov/dei/2019-01-31 true true JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cooper8kq22020form.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "coo-20200604_cal.xml" ] }, "definitionLink": { "local": [ "coo-20200604_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cooper8kq22020form.htm" ] }, "labelLink": { "local": [ "coo-20200604_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "coo-20200604_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "coo-20200604.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "coo", "nsuri": "http://www.coopercos.com/20200604", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cooper8kq22020form.htm", "contextRef": "D2020Q2", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.coopercos.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "cooper8kq22020form.htm", "contextRef": "D2020Q2", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.coopercos.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 15 cooper8kq22020form_htm.xml IDEA: XBRL DOCUMENT 0000711404 2020-06-04 2020-06-04 false 0000711404 8-K 2020-06-04 THE COOPER COMPANIES, INC. DE 1-8597 94-2657368 6101 Bollinger Canyon Road Suite 500 San Ramon CA 94583 925 460-3600 false false false false Common Stock, $.10 par value COO NYSE false XML 16 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }